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Abstract A heat-stable activator for ADP-ribosylation factor
(ARF)-dependent phospholipase D (PLD) was purified to near
homogeneity from rat kidney cytosol by a sequential column
chromatography. The purified activator has a molecular mass of
23 kDa on SDS-PAGE. Using a partially purified ARF-
dependent PLD from rat kidney, the activator synergistically
stimulates PLD with ARF in time- and dose-dependent manner.
In the absence of ARF, the activator has little or no effect. The
purified activator also stimulates PLD under several conditions
including permeabilized cell system, suggesting that the activator
is a physiologically relevant regulator of PLD.
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1. Introduction
The hydrolysis of phosphatidylcholine (PtdCho) by phos-
pholipase D (PLD) is elicited by a wide variety of external
signals (for reviews, see [1,2]). The mechanism of PLD acti-
vation has attracted considerable attention because the en-
zyme has been implicated in the regulation of many cellular
responses including mitogenesis in ¢broblasts, intracellular
protein tra⁄cking, and apoptosis [3^5]. Recently, it has be-
come evident that several factors are involved in the activation
of PLD. As lipid factors, phosphatidylinositol 4,5-bisphos-
phate (PtdIns-4,5-P2) [6^8] and phosphatidylethanolamine
(PtdEtn) [9] are shown to be essential for exhibiting PLD
activity. Small GTP-binding regulatory proteins (G-proteins)
such as ADP-ribosylation factor (ARF) [6,10] and RhoA
[11,12] are shown to activate PLD. PLD obtained from hem-
atopoietic cell lines is activated by coexistence of a 50-kDa
soluble protein and either ARF [13,14] or RhoA [15]. Brain
PLD is activated by a cytosolic factor in a manner synergistic
to ARF [16], and this cytosolic factor is indistinguishable
from protein kinase C (PKC) [17,18].
A preceding report from this laboratory has described that
under resting conditions membrane-bound PLD is in a latent
form, but exhibits a high activity in the presence of ammo-
nium sulfate, guanosine 5P-O-(3-thiotriphosphate) (GTP-Q-S),
and cytosol [19]. The active component in the cytosol consists
of three protein factors: ARF, RhoA, and a soluble heat-
stable protein [20]. The heat-stable protein is now puri¢ed
to near homogeneity from rat kidney cytosol. Some properties
of this activator are described here.
2. Materials and methods
2.1. Materials
1,2-Di-[1-14C]palmitoyl-sn-glycero-3-phosphocholine ([14C]PtdCho,
115 mCi/mmol) and 1-[1-14C]palmitoyl-2-lyso-sn-glycero-3-phospho-
choline ([14C]lysoPtdCho, 57.0 mCi/mmol) were purchased from Du-
Pont-New England Nuclear. [Q-32P]ATP was from Amersham. Phos-
phatidylethanol (PtdEtOH), a standard for TLC, was from Avanti
Polar-Lipid, Inc. Plasmalogen-rich PtdEtn (60% plasmalogen) was
from Serdary Research Laboratories (Englewood Cli¡s, NJ). GTP-Q-
S was from Boehringer-Mannheim. Glass-backed silica gel 60 was
purchased from Merck. Streptolysin-O was obtained from Murex Di-
agnostics. Phorbol 12-myristate 13-acetate (PMA) was a product of
LC services (Woburn, MA). Other chemicals were of analytical grade.
2.2. Cells
HL-60 cells were maintained at a cell density between 0.1 and
1.0U106 cells per ml as a suspension in RPMI 1640 medium supple-
mented with 5% fetal bovine serum (Flow Laboratories) at 37‡C in a
humidi¢ed 5% CO2/95% O2 atmosphere.
2.3. Preparation of PLD
PLD was partially puri¢ed from kidney particulate fraction as de-
scribed previously [20] except that rat kidney was used instead of
bovine kidney, and that hydroxyapatite column chromatography
was omitted from the puri¢cation procedure. The PLD preparation
after TSK heparin 5PW column chromatography was puri¢ed about
200-fold in its speci¢c activity from the particulate fraction. This
preparation was free of ARF and the heat-stable PLD activator.
The PLD activity was stable at least for two weeks at 380‡C.
2.4. Preparation of ARF
ARF was puri¢ed from bovine brain as described [21]. Final prep-
aration of ARF after gel ¢ltration (HiLoad 16/60 Superdex 75 (Phar-
macia; 1.6U60 cm)) was about 87% pure by silver stain. This prep-
aration was free of the heat-stable PLD activator as judged by SDS-
PAGE [22].
2.5. PLD assay in cell-free systems
PLD activity was determined by measuring the formation of
[14C]PtdEtOH from [14C]PtdCho in the presence of ethanol. The re-
action mixture contained PLD partially puri¢ed from rat kidney,
ARF, GTP-Q-S, ammonium sulfate, [14C]PtdCho, PtdEtn, and each
fraction to be assayed. The detailed conditions are described elsewhere
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[20]. [14C]PtdCho and PtdEtn were separately dried and dispersed by
sonication in distilled water and added to the reaction mixture. In
some studies PLD activity was determined by measuring the forma-
tion of [14C]PtdEtOH from [14C]PtdCho with PtdIns-4,5-P2 and
PtdEtn as lipid activators as described [6].
2.6. PLD assay in permeabilized cells
HL-60 cells were preincubated with [14C]lysoPtdCho (0.5 WCi/
1U107 cells) for 1 h at 37‡C. Labeled cells (5U105 cells) were incu-
bated in a total volume of 100 Wl with 0.4 i.u./ml streptolysin-O, 100
WM GTP-Q-S, 3 mM MgCl2, 0.5 mM ATP, 0.1 WM free Ca2 in Ca2-
EGTA bu¡er, 2% ethanol, and various concentrations of heat-stable
PLD activator as indicated in the presence or absence of 100 nM
PMA for 20 min at 37‡C. Radioactive PtdEtOH produced was ex-
tracted and quantitated as described [23].
2.7. Other procedures
Conventional PKC was puri¢ed from rat brain as described [24].
One unit of PKC was expressed as 1 pmol of [Q-32P]ATP incorporated
into myelin basic protein per 5 min. Protein was determined by the
method of Bradford [25].
3. Results
3.1. Puri¢cation of heat-stable PLD activator
Cytosolic fraction from rat kidney was prepared as de-
scribed earlier [19]. Protein of the cytosolic fraction (1250
mg protein) was precipitated with ammonium sulfate (30^
70% saturation), dissolved and dialyzed as described [19].
The dialysate was heated for 10 min at 60‡C. After cooling
on ice, heat-denatured materials were removed by centrifuga-
tion for 10 min at 20 000Ug. The supernatant was concen-
trated to about 5 ml with an Amicon ultra¢ltration cell
equipped with PM-10 membrane, and applied to a gel ¢ltra-
tion column, HiLoad 16/60 Superdex 75 (Pharmacia; 1.6U60
cm) which had been equilibrated with bu¡er A (50 mM
HEPES-NaOH at pH 7.4, 1 mM MgCl2, 1 mM EGTA, and
1 Wg/ml leupeptin). The activator was eluted from the column
with the same bu¡er at a £ow rate 1 ml/min using an FPLC
system (Pharmacia). Fractions (5 ml each) were collected. An
aliquot (20 Wl) of each fraction was assayed for PLD activa-
tion (Fig. 1A). PLD activator (fractions 14 through 16) was
applied to a DEAE 5PW column (Toyo Soda (Tokyo);
2.15U15 cm) which had been equilibrated with bu¡er A.
After washing the column with bu¡er A, PLD activator was
eluted stepwise with bu¡er A containing 0.1 M NaCl at a £ow
rate of 1 ml/min (Fig. 1B). Fractions (2 ml each) were col-
lected. Fractions 14 through 15 containing PLD activator
were pooled, brought to 3 M NaCl by adding solid NaCl,
and applied to a Phenyl 5PW column (Toyo Soda (Tokyo);
2.15U15 cm) which had been equilibrated with bu¡er A con-
taining 2 M NaCl. After washing the column with bu¡er A
containing 2 M NaCl, PLD activator was eluted stepwise with
bu¡er A at a £ow rate of 1 ml/min (Fig. 1C). Fractions (2 ml
each) were collected. Fraction 7 which contained PLD activa-
tor was applied to a Hi-Trap Octyl Sepharose 4 FF column
(Pharmacia; 0.7U2.5 cm; 1 ml) which had been equilibrated
with bu¡er A. After washing the column with bu¡er A, PLD
activator was eluted stepwise with bu¡er A containing 1% 1-
octyl L-glucopyranoside (octylglucoside) at a £ow rate of
1 ml/min. Fractions (2 ml each) were collected. Fractions 12
through 14 containing PLD activator were pooled and applied
to a Resource Q column (Pharmacia; 0.64U3 cm; 1 ml)
which had been equilibrated with bu¡er A. After washing
the column with bu¡er A, PLD activator was eluted stepwise
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Fig. 1. Elution pro¢les of a heat-stable activator protein for PLD. Each fraction (20 Wl) was assayed for PLD activation in the presence of 200
nM ARF under standard conditions. b, PLD activity; dotted line, absorbance at 280 nm. A: Superdex 75 column chromatography. B: DEAE
5PW column chromatography. The arrow indicates the start of elution with bu¡er A containing 0.1 M NaCl. C: Phenyl 5PW column chroma-
tography. The arrow indicates the start of elution with bu¡er A. D: Resource Q column chromatography. The arrow indicates the elution with
bu¡er A containing 0.1 M NaCl.
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with bu¡er A containing 0.1 M NaCl at a £ow rate of 1 ml/
min (Fig. 1D). Fractions (2 ml each) were collected. The ac-
tive fractions contained 23-kDa protein estimated by SDS-
PAGE (Fig. 2). The purity of the 23-kDa protein was esti-
mated to be more than 95% by SDS-PAGE analysis ; the
distribution of the 23-kDa protein coincided exactly with
that of PLD-stimulating activity. The ¢nal preparation
showed a 11 700-fold increase in the speci¢c activity with an
overall yield of 28% (Table 1). PLD activator at this stage of
puri¢cation was used for subsequent studies. PLD activator
was stable at least several months at 380‡C.
3.2. Characterization of heat-stable PLD activator
The heat-stable PLD activator caused a marked stimulation
of ARF-dependent PLD in a dose-dependent manner (Fig.
3A). Half-maximal stimulation was observed at 45 ng/assay
and a maximal stimulation was obtained at 130 ng/assay.
Higher concentrations of the activator caused a slight inhib-
ition. In the absence of ARF, the heat-stable activator showed
a very weak stimulatory e¡ect if any. The reaction in the
presence of both ARF and the heat-stable activator linearly
proceeded for 40 min and then became plateau (Fig. 3B).
About 55% of total PtdCho was converted to PtdEtOH after
80 min incubation.
3.3. Stimulation by heat-stable activator of PLD under
di¡erent assay systems
The ability of the heat-stable activator was assessed by dif-
ferent PLD assay systems. Fig. 4A and B show the activation
of ARF-dependent PLD by the heat-stable activator or by
PKC under the method reported by Brown et al. [6]. The
heat-stable activator caused PLD stimulation in a dose-de-
pendent manner to the similar extent as caused by PKC
plus PMA. In this condition the heat-stable activator (130
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Table 1
Puri¢cation of a heat-stable activator protein for PLD
Puri¢cation Protein (mg) Speci¢c activity (pmol/min/mg) Total activity (pmol/min) Puri¢cation (fold) Yield (%)
Supernatant 1250 1.24 1550 1 100
AS precipitation 178 17.1 3040 14 196
Superdex 75 53 93.9 4980 76 321
DEAE 5PW 6.9 620 4280 500 276
Phenyl 5PW 2.9 562 1630 453 105
Octyl Sepharose 0.04 ND ND ND ND
Resource Q 0.03 14 500 435 11 700 28
PLD activity was measured with 100 ng of enzyme, 200 nM ARF, and the heat-stable activator at various stages of puri¢cation in Section 2. The
activator activity is de¢ned as the increased amount of [14C]PtdEtOH per min by subtracting the value without the activator. Octylglucoside was
highly inhibitory to PLD reaction [9], the activity after Octyl Sepharose column was not detected. ND, not detected.
Fig. 3. Characteristics of enhancement of ARF-dependent PLD ac-
tivity by puri¢ed heat-stable activator. A: Requirement of heat-sta-
ble activator for ARF-dependent PLD activation. Various concen-
trations of the puri¢ed heat-stable activator as indicated were
assayed for PLD activation in the presence (b) or absence (a) of
200 nM ARF with the reaction mixture (100 Wl) containing 100 ng
of PLD, 60 WM [14C]PtdCho (13 750 dpm/nmol), 70 WM PtdEtn, 2%
ethanol, 1.6 M ammonium sulfate, 100 WM GTP-Q-S, 1 mM MgCl2,
and 20 mM HEPES-NaOH at pH 7.4 as described [20]. B: Time
course of PLD activation. b, with 200 nM ARF and heat-stable ac-
tivator (130 ng/assay); a, with 200 nM ARF.
Fig. 2. Analysis of puri¢ed heat-stable activator on SDS-PAGE.
Aliquots of the samples from Resource Q column chromatography
(Fig. 1D) were subjected to SDS-PAGE on a 12.5% gel followed by
silver stain. The positions of molecular weight markers are indicated
in kDa.
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ng) and PKC (10 units) plus PMA caused almost additive
stimulation of PLD (not shown). The ability of the heat-stable
activator was also assessed by streptolysin-O-permeabilized
HL-60 cell system in which membrane PtdCho was metabol-
ically labeled with [14C]lysoPtdCho. In streptolysin-O-permea-
bilized HL-60 cells the heat-stable activator enhanced PLD
activity in a synergistic manner with PMA (Table 2).
4. Discussion
The activator described here was found earlier as a heat-
stable protein which e¡ectively enhanced PLD activity in the
simultaneous presence of ARF and RhoA [20]. In the present
studies RhoA was excluded from the PLD assay because this
protein is not obligatory for PLD activation [20]. The puri¢ed
heat-stable activator has a molecular mass of 23 kDa esti-
mated by SDS-PAGE (Fig. 2). In the previous study the mo-
lecular mass of the heat-stable PLD activator was estimated
to be 36 kDa by gel ¢ltration [20]. Possible reasons for the
discrepancy of the molecular size may be ascribed to di¡erent
methodology used for the estimation or complex formation
with other proteins in the crude preparations.
There are at least two types of mammalian PLD that have
recently been cloned [26^28]. PLD1 is an ARF-dependent
PLD which requires PtdIns-4,5-P2 for its activity [26]. There
are two splice variants of PLD1 (PLD1a and PLD1b) with
similar biochemical properties and regulation [27]. PLD2 is an
ARF-independent enzyme whose activity is also stimulated by
PtdIns-4,5-P2 [28]. Kidney PLD used in the present study is
similar to PLD1a or PLD1b in that kidney PLD is an ARF-
dependent enzyme and is also stimulated by RhoA [20,27].
Relationship between the kidney PLD and PLD1 remains to
be studied.
There are several reports concerning the cytosolic protein
activators for PLD [13^15,17,18]. The heat-stable activator
may not be a proteolytic product of PKC. Polyclonal anti-
body against a synthetic peptide around the N-terminal por-
tion of K-subspecies of PKC did not recognize the activator
[20]. Furthermore, PMA has no e¡ect on the activation of
PLD by the activator. PLD obtained from hematopoietic cells
is shown to be activated by a 50-kDa soluble protein and
either ARF [13,14] or RhoA [15]. The heat-stable activator
also activated PLD associated with HL-60 cell membrane in
an ARF-dependent manner (not shown). The relationship be-
tween the heat-stable activator and the 50-kDa soluble protein
remains to be clari¢ed.
It is unlikely that the heat-stable activator stimulates PLD
by interacting with and activating ARF because the activator
has no e¡ect on the [35S]GTP-Q-S binding to ARF [20]. The
precise mechanism of activation of ARF-dependent PLD by
the heat-stable activator and the structural analysis of the
protein remain to be elucidated.
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